Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Philadelphia Pharmaceuticals Company

Market Cap 12.52M 17.67M 15.25M 14.02M 13.19M 24.79M 1.67B 25M 166M 64.67M 819M 66.33M 64.91M 2.83B P/E 2024
13.7x
P/E 2025 11.9x
Enterprise Value 12.46M 17.58M 15.16M 13.94M 13.12M 24.66M 1.66B 24.86M 165M 64.32M 814M 65.97M 64.56M 2.82B EV / Sales 2024
1.32x
EV / Sales 2025 1.3x
Free-Float
7.27%
Yield 2024
4.67%
Yield 2025 -
1 day-0.60%
1 week-0.60%
Current month-2.91%
1 month+1.21%
3 months+5.03%
6 months+7.74%
Current year+4.38%
1 week 1.67
Extreme 1.67
1.67
1 month 1.66
Extreme 1.66
1.74
Current year 1.5
Extreme 1.5
1.74
1 year 1.45
Extreme 1.45
1.74
3 years 1.34
Extreme 1.34
1.74
5 years 1.28
Extreme 1.28
1.74
10 years 1.28
Extreme 1.28
3.42
Manager TitleAgeSince
Chief Executive Officer 44 2012-12-31
Chief Tech/Sci/R&D Officer - -
Director of Finance/CFO 50 2001-12-31
Director TitleAgeSince
Chairman 58 -
Director/Board Member 61 2016-08-31
Director/Board Member 64 2012-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.60%-0.60%+14.38%+28.46% 17.78M
+1.09%+2.33%+8.02%+83.51% 45.7B
+2.03%+2.87%+46.54%+90.11% 34B
-1.63%-1.87%-11.54%+34.27% 11.73B
-1.60%-4.00%+8.93%+92.61% 11.48B
+1.99%+3.12%+39.68%+130.57% 9.28B
-0.92%-0.17%+16.72%+41.32% 7.21B
-0.42%+1.63%+44.06%-18.50% 6.62B
-0.93%-3.30%+26.92%+232.57% 6.44B
-0.63%-4.16%-44.00%-7.82% 5.01B
Average -0.16%+0.08%+14.97%+70.71% 13.75B
Weighted average by Cap. +0.59%+0.50%+19.27%+81.40%

Financials

2024 2025
Net sales 8.76M 12.36M 10.67M 9.81M 9.23M 17.34M 1.17B 17.49M 116M 45.24M 573M 46.4M 45.41M 1.98B 9.17M 12.94M 11.16M 10.26M 9.66M 18.15M 1.22B 18.3M 122M 47.34M 599M 48.55M 47.52M 2.07B
Net income 822K 1.16M 1M 919K 865K 1.63M 109M 1.64M 10.89M 4.24M 53.69M 4.35M 4.26M 186M 1.01M 1.42M 1.22M 1.12M 1.06M 1.99M 134M 2.01M 13.33M 5.19M 65.69M 5.32M 5.21M 227M
Net Debt 334K 471K 406K 373K 351K 660K 44.42M 666K 4.42M 1.72M 21.8M 1.77M 1.73M 75.42M -67.69K -95.5K -82.39K -75.75K -71.29K -134K -9.01M -135K -898K -349K -4.42M -358K -351K -15.3M
Logo Philadelphia Pharmaceuticals Company
Philadelphia Pharmaceuticals Industry Company PSC is a Jordan-based company that is engaged in the development, manufacture and marketing of human pharmaceutical products of different therapeutic categories. The Company, through its production facilities and laboratories located in Amman Industrial state, develops and produces a number of products that includes: Semisolid Dosage Forms, such as creams, ointments, lotions, gels and suppositories, as well as Liquid Dosage Forms, which include syrups, suspensions, solutions, nasal, drops, mouth washes and vaginal douches. Furthermore, the Company undertakes the distribution and marketing of a range of healthcare systems, miscellaneous and pharmaceuticals of different international brand names, including alimentary, gastrointestinal systems and respiratory systems. The Company markets its products to the local markets and exports to more than 10 countries in the Middle East and North Africa region.
Employees
129
Date Price Change Volume
26-06-16 1.670 JOD -0.60% 85
  1. Stock Market
  2. Stocks
  3. PHIL Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!